Interim HealthCare Franchise Due Diligence

About Interim HealthCare Franchise

Home health care franchise providing nursing, therapy, hospice, and personal care services.

The total initial investment for a Interim HealthCare franchise ranges from $156,200 to $309,250, which includes the initial franchise fee of $50,000. These figures come from the most recently available Franchise Disclosure Document (FDD) filed with state regulators.

Beyond the initial investment, franchisees pay ongoing royalties of Varies and marketing/advertising contributions of Included in royalty. These ongoing fees significantly impact your real profit margin, and they are often underestimated by prospective franchisees.

What the Interim HealthCare FDD reveals

Based on the Interim HealthCare Inc. 2025 Franchise Disclosure Document, SharpSheets October 2025 Interim HealthCare analysis, FranchisePayback 2025 FDD summary, Franchise Direct 2025 FDD summary, VettedBiz Interim HealthCare profile, Franchise Chatter FDD Talk September 2018 historical review (2018 FDD), FranChimp FDD database, Entrepreneur 2025 profile, the Caring Brands International corporate materials, Wellspring Capital Management portfolio disclosures, and the official Interim HealthCare franchising portal at interimfranchising.com. Interim HealthCare Inc. (IHI) is a Florida corporation with principal business address at 1601 Sawgrass Corporate Parkway, Sunrise, Florida 33323. IHI is a wholly-owned subsidiary of IH Acquisition Corp (IHAC), which is a wholly-owned subsidiary of Caring Brands International, Inc. (CBII). CBII's principal address is 345 North Maple Drive, Suite 300, Beverly Hills, California 90210. In October 2021, Wellspring Capital Management, a New York private equity firm, acquired Caring Brands International, bringing Interim HealthCare under PE ownership. The brand was founded in 1966 (originally as Medical Personnel Pool); it was the first provider in the country to supply supplemental staff relief in healthcare facilities and helped change Medicare laws to allow proprietary companies to become Medicare providers. The brand changed its name to Interim HealthCare in 1992 to reflect the expanded service continuum. Per SharpSheets 2025 and FranchisePayback 2025 summaries, Interim HealthCare operates over 320 locations across 44 states. The brand provides a full continuum of home-based care including skilled home healthcare, hospice care, healthcare staffing, personal care assistance, and specialized medical care. Interim HealthCare ranked #102 on Entrepreneur's 2018 Franchise 500 list.

Item 5 and 6: Fee Structure

Initial franchise fee per VettedBiz analysis of the 2024-2025 FDD is approximately $75,000 per unit. Total initial investment per Item 7 varies materially by disclosure source and product tier: SharpSheets October 2025 reports $385,000 to $462,000; VettedBiz reports $156,000 to $239,000 (which may reflect a different product tier such as pure Home Care versus full Home Healthcare plus Hospice combined). The variance likely reflects that Interim HealthCare offers multiple Franchise Agreement types: Home Healthcare (skilled medical care requiring higher capital for clinical infrastructure), Hospice Franchise (terminal care requiring additional regulatory compliance), Healthcare Staffing (primarily staffing supplemental personnel), and Personal Care (non-medical companionship and home assistance). Ongoing royalty per SharpSheets October 2025 ranges from 3.5% to 5.5% of sales depending on service type (with clinical/skilled services typically at lower royalty tiers given higher labor cost ratios). This variable royalty by service type is structurally different from the fixed 5-7% royalty common in Health & Wellness franchises and provides meaningful economic alignment with higher-margin personal care services. Upon termination or non-renewal of the Franchise Agreement, per the Franchise Direct 2025 summary directly quoting the FDD: "all customers, contracted providers and goodwill may, at our option, belong to us." This clause is material and economically significant.

Item 19: Earnings Disclosure

Per VettedBiz analysis of the 2024-2025 FDD, yearly gross sales of approximately $1,658,044 and estimated earnings of $298,448 to $414,511 per franchise location. These are strong category-level earnings figures (18% to 25% estimated earnings as a percentage of gross sales). Payback period estimated at 1.6 to 3.6 years per VettedBiz, materially faster than most capital-intensive Health & Wellness franchises (compare Massage Envy at 5.6-7.6 years). Historical Item 19 per Franchise Chatter FDD Talk September 2018 (covering 2017 data) reported on 174 Qualifying Franchisees that operated for the entire 2017 calendar year and 108 Qualifying Franchisees that operated more than one Area for the entire year. The by-years-in-operation segmentation allows prospective franchisees to model realistic ramp expectations (Year 1, Year 2, Year 3+ mature operations). Multi-Area operators (108 of 174 in 2017, approximately 62%) substantially outperform single-Area operators, which is a recurring pattern in home healthcare franchising and suggests the economic model rewards multi-territory development. The Item 19 methodology separately reports home healthcare sales and staffing sales, which is useful for modeling revenue mix. Prospective franchisees should request the complete current Item 19 data directly and validate against existing franchisee references per Item 20, with particular attention to ramp-year performance and revenue mix by service type.

Item 20: Unit Count and Growth Trajectory

Per current 2025 brand disclosures, Interim HealthCare operates over 320 locations across 44 states. The network is relatively stable but has been in modest contraction from historical peak (Franchise Chatter 2018 analysis referenced a larger network; SharpSheets notes "over 300 independently owned franchises"). Home healthcare industry contraction during the late 1990s and early 2000s was severe (approximately one-third of home health agencies failed); Interim HealthCare survived by diversifying the service continuum and operating a differentiated Medicare-certified skilled care model that many smaller competitors could not sustain. Franchise Agreement term and renewal conditions are specified in Item 17 of the current FDD. The 2021 Wellspring Capital Management acquisition is a material ownership change that typically drives franchisor-level operational and fee structure modifications. Item 3 litigation disclosures are noted by VettedBiz as material: "this franchise discloses lawsuits and/or bankruptcy information in its FDD, which may impact your evaluation." Prospective franchisees should review the complete Item 3 directly with independent counsel familiar with healthcare regulatory compliance.

Top 3 Red Flags

1. Franchise Agreement termination/non-renewal clause transfers "all customers, contracted providers and goodwill" to the franchisor at the franchisor's option, creating asymmetric exit economics and post-termination restriction exposure for franchisees who have invested years building local healthcare relationships. Per Franchise Direct 2025 FDD summary directly quoting the Franchise Agreement: "Upon termination or non-renewal of the Franchise Agreement, all customers, contracted providers and goodwill may, at our option, belong to us." This clause is structurally unusual and economically significant. In most service franchises, customer relationships developed by the franchisee over the franchise term carry some residual value at exit (either sale to a successor franchisee or conversion to an independent business post-non-compete). Interim HealthCare's contractual language specifies that at termination or non-renewal, the franchisor can unilaterally claim all customer relationships (which in home healthcare are the primary asset), all contracted providers (independent caregivers and referral-source agreements), and all goodwill (brand recognition, local reputation, referral networks with hospitals and discharge planners). The economic implication: a franchisee who invests 10+ years building clinical referral relationships with hospitals, discharge planners, and physician groups, who develops local caregiver recruitment infrastructure, who maintains Medicare certification, who builds multi-million-dollar revenue on a $385K-$462K investment, can lose that entire accumulated asset value at Franchise Agreement termination or non-renewal at the franchisor's unilateral option. This creates franchisor-favorable leverage at renewal negotiations. Before signing, demand written clarification of: the specific circumstances under which the franchisor would exercise this claim, post-termination non-compete provisions and their enforceability in your state, transfer provisions if you want to sell to a successor operator, and the franchisor's historical practice of exercising this right (how frequently, in what circumstances, with what economic outcome to the exiting franchisee).
2. Home healthcare industry faces multiple structural regulatory pressures including Medicare reimbursement rate reform, CMS hospice and home health compliance initiatives, state-level caregiver labor regulation, and proposed Department of Labor independent contractor reclassification that collectively create material ongoing compliance cost and revenue visibility challenges. The Interim HealthCare service continuum spans Medicare-certified skilled home healthcare, Medicare-certified hospice care, Medicaid waiver programs (state-level variability), private pay personal care, and institutional healthcare staffing. Each service tier has distinct regulatory exposure. Medicare reimbursement: CMS has implemented multiple home health reimbursement rate reforms over 2020-2025 including the Patient-Driven Groupings Model (PDGM), Home Health Value-Based Purchasing Model expansion, and annual Medicare rate adjustments that have been pressured by CMS cost-containment initiatives. Hospice compliance: CMS has increased audit activity on hospice eligibility documentation with substantial clawback exposure (hospice providers must document terminal prognosis with specific clinical evidence; audit findings can require return of months of reimbursement). Caregiver labor regulation: state-level initiatives (particularly California AB5 and similar laws in NY, NJ, IL, MA) have reclassified or threatened to reclassify home healthcare workers from independent contractor to employee status, materially increasing operator labor cost. Department of Labor 2024-2025 independent contractor rule: ongoing federal-level reclassification pressure. Medicaid waiver programs: state-by-state variability and budget pressure. Franchisees operating multiple service tiers face compounding regulatory complexity that smaller independent operators often cannot sustain (which is both an opportunity and a risk). Before signing, demand: specific regulatory compliance support infrastructure provided by franchisor, Medicare-certification application and audit defense support, state-specific caregiver classification guidance, and 3-year trailing franchisee audit and clawback exposure data.
3. 2021 Wellspring Capital Management acquisition introduces fresh private-equity ownership with typical 5-7 year hold period creating uncertainty around fee structure, product mix, and support infrastructure through 2026-2028. Wellspring Capital Management acquired Caring Brands International (Interim HealthCare's parent) in October 2021. Typical PE hold periods are 5-7 years, which means a Wellspring exit is probable in the 2026-2028 window via secondary PE sale, strategic buyer acquisition, or public offering. PE ownership transitions typically drive operational and fee-structure modifications including: renegotiated Regional Developer territory rights, modifications to Franchise Agreement terms at renewal, product mix pressure (emphasis on higher-royalty service tiers), shared-services allocations between Caring Brands International franchise brands (which include Interim HealthCare plus other senior care and staffing concepts per Caring Brands portfolio), and change-of-control transactions that can affect franchisee rights and obligations. Wellspring Capital Management's prior franchise sector investments inform the likely strategic playbook: cost optimization at the franchisor level, growth of high-margin service tiers, and EBITDA optimization for exit valuation. Prospective franchisees signing Franchise Agreements in 2026 are signing into a system that will likely change ownership before the end of their initial Franchise Agreement term. Before signing, demand written clarification of: Wellspring Capital Management's stated Interim HealthCare strategy and exit timeline, change-of-control provisions in your Franchise Agreement, any planned fee structure or operational modifications through 2028, and protections for franchisee rights at change-of-control.

Verdict

Best fit for experienced healthcare operators with prior home healthcare, hospice, or Medicare-certified provider experience, buyers with strong regulatory compliance capability (Medicare conditions of participation, state licensure, CMS audit defense), multi-territory operators seeking Regional Developer opportunities (the historical data shows multi-Area operators materially outperform single-Area), candidates with $250K+ liquid capital comfortable with the $385K-$462K investment range, and operators in markets with aging population demographics and limited Medicare-certified competitor density. The strong Item 19 performance ($1.66M average gross sales, 18-25% estimated earnings, 1.6-3.6 year payback per VettedBiz) supports the investment thesis for well-qualified operators. Not a good fit for first-time franchise buyers, single-territory operators unwilling to pursue multi-Area development, candidates without healthcare regulatory compliance experience, buyers uncomfortable with the franchisor's termination/non-renewal customer-goodwill claim provision, operators in markets with existing strong Medicare-certified competitor density, or buyers expecting stable ownership through their Franchise Agreement term (Wellspring exit is probable 2026-2028). Before signing, demand written clarification of: termination and non-renewal provisions and their economic consequences, post-termination non-compete enforceability, Medicare certification and audit defense support, Wellspring Capital's stated strategy and exit timeline, change-of-control provisions, and specific Item 19 quartile data for operators in comparable market sizes.

This analysis reflects patterns visible in the Interim HealthCare Inc. 2025 FDD, SharpSheets October 2025 Interim HealthCare analysis, FranchisePayback 2025 FDD summary, Franchise Direct 2025 FDD summary, VettedBiz profile, Franchise Chatter FDD Talk September 2018 historical review, FranChimp FDD database, Entrepreneur 2025 profile, Caring Brands International corporate materials, Wellspring Capital Management portfolio disclosures, and the official Interim HealthCare franchising portal. Your specific Franchise Agreement terms (Home Healthcare, Hospice, Staffing, or Personal Care tier), Regional Developer territory, Medicare certification status and support, termination and non-renewal provisions, state-specific regulatory compliance exposure, and change-of-control provisions relative to Wellspring Capital ownership require review of your actual agreements with independent legal counsel familiar with healthcare franchise operations. Have our AI FDD Analyzer review your specific Franchise Agreement for deal-level red flags.

Compare Interim HealthCare with similar franchises

Buyers evaluating Interim HealthCare typically also review these related FDD analyses for structural, unit-economics, and ownership comparison.

• Home Instead - Health & Wellness category comparison: skilled Medicare-certified home healthcare vs non-medical senior companionship care
• Seniors Helping Seniors - Health & Wellness category comparison: multi-tier skilled healthcare franchise vs peer-caregiver matching model
• Massage Envy - Health & Wellness category comparison: $1.66M AUV home healthcare with 1.6-3.6 year payback vs $1.1M membership-based massage franchise

Key Questions Before Investing in Interim HealthCare

These are the due diligence questions most buyers skip before signing a franchise agreement. They go beyond what's in the FDD.

• What is the realistic Year 1 take-home pay? After royalties (Varies), ad fund contributions (Included in royalty), rent, labor, COGS, insurance, and debt service. What do you actually keep? Use our Profit Margin Calculator to find out.
• What is the closure rate? Check Item 20 of the FDD. How many Interim HealthCare locations have closed, been terminated, or "ceased operations" in the last three years? A high number is a red flag.
• Are the territories truly protected? Item 12 defines your territory. Does Interim HealthCare reserve the right to sell through alternative channels (delivery apps, online, grocery) in your territory? Many do.
• What happens when you want out? Item 17 covers renewal, termination, and transfer. What does Interim HealthCare charge to transfer? Is there a non-compete after you leave? How long?
• What do current and former franchisees say? The FDD lists every franchisee's name and phone number. Call at least 10 current and 5 former ones. Our Validation Call Scripts tool gives you the exact questions to ask.
• Does the franchisor make money from you or with you? Check Item 21 (audited financials). Does Interim HealthCare earn most of its revenue from royalties on operating franchisees, or from selling new franchise licenses? The latter is a warning sign.
• Can you afford to lose this money? If Interim HealthCare fails in 18 months, what is your total financial exposure including the lease, SBA loan personal guarantee, and sunk costs? If the answer makes you sick, reconsider.

Other Health & Wellness Franchises to Compare

Smart due diligence means comparing alternatives. Here are other health & wellness franchises you should evaluate alongside Interim HealthCare.